Kindeva wins £33M grant to enhance drug

August 4, 2023 By Sean Whooley

Kindeva Drug Delivery announced that it received a grant from a UK fund worth a $42.2 million (£33 million) investment.

The grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSIMF) aims to help Kindeva enhance inhaler manufacturing and sustainability. Funds improve Kindeva’s capability and capacity to manufacture the next generation of green pressurized metered-dose inhalers (pMDIs).

Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug-Device Combinations, Funding Roundup Tagged With: Kindeva Drug Delivery